Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX:MCRO)

Market Cap	638.63M
Revenue (ttm)	879.03M
Net Income (ttm)	131.91M
Shares Out	570.21M
EPS (ttm)	0.23
PE Ratio	4.87
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,755,323
Average Volume	7,943,991
Open	1.120
Previous Close	1.120
Day's Range	1.110 - 1.130
52-Week Range	0.808 - 4.110
Beta	0.29
RSI	34.81
Earnings Date	Feb 26, 2026

About EGX:MCRO

Macro Group Pharmaceuticals (Macro Capital) S.A.E operates as a cosmeceuticals manufacturing company in Egypt and internationally. It engages in the production of pharmaceutical and cosmetic products, such as skin care, hair care, oral care, female intimate care, anti-scar, antiseptics, and topical muscle relaxants, as well as flavors, colors, and scents. The company also manufactures solid and liquid soap, herbal medicines, products and extracts, nutritional supplements, baby food, and special food products. It also offers its products online....

• Industry: Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 2002
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: MCRO

Financial Performance

In 2024, EGX:MCRO's revenue was 519.97 million, a decrease of -1.15% compared to the previous year's 526.01 million. Losses were -38.10 million, -86.03% less than in 2023.